Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder : A pooled analysis of phase III clinical trials

被引：0
|
作者：
Khan, A. [1 ]
Song, W. [2 ]
Ruth, A. [3 ]
Edwards, J. [4 ]
机构：
[1] Duke Univ, Bellevue, WA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
[4] Forest Res Inst, Jersey City, NJ USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-14-022
引用
收藏
页码：186 / 187
页数：2
相关论文
共 50 条
  • [21] Efficacy of lumateperone in pooled short-term late-phase clinical trials for the treatment of major depressive episodes associated with bipolar II disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Changzheng
    D'Souza, Ian
    McIntyre, Roger S.
    [J]. BIPOLAR DISORDERS, 2023, 25 : 99 - 99
  • [22] Efficacy of Lumateperone in Pooled Short-Term Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar II Disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Richard
    D'Souza, Ian
    McIntyre, Roger S.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 192 - 193
  • [23] Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder
    Kasper, S.
    Baldwin, D.
    Boulenger, J. P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S297 - S298
  • [24] Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials
    Lam, Raymond W.
    Andersen, Henning F.
    Wade, Alan G.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 181 - 187
  • [25] Efficacy of Lumateperone in Pooled Short-Term LatePhase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar II Disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Richard
    D'Souza, Ian
    McIntyre, Roger S.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 192 - 193
  • [26] Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
    Khan, Arif
    Sambunaris, Angelo
    Edwards, John
    Ruth, Adam
    Robinson, Donald S.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (02) : 86 - 92
  • [27] Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials
    Gorman, Jack M.
    Korotzer, Andrew
    Su, Guojin
    [J]. CNS SPECTRUMS, 2002, 7 (04) : 40 - 44
  • [28] VILAZODONE: A NEW TREATMENT OPTION FOR MAJOR DEPRESSIVE DISORDER
    Owen, R. T.
    [J]. DRUGS OF TODAY, 2011, 47 (07) : 531 - 537
  • [29] Evidence for the use of vilazodone in the treatment of major depressive disorder
    Reinhold, Jennifer A.
    Mandos, Laura A.
    Lohoff, Falk W.
    Rickels, Karl
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2215 - 2224
  • [30] Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
    Thase, Michael E.
    Chen, Dalei
    Edwards, John
    Ruth, Adam
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (06) : 351 - 356
12345